BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh G, Nassri A, Kim D, Zhu H, Ramzan Z. Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma. World J Gastrointest Pharmacol Ther 2017; 8(1): 60-66 [PMID: 28217375 DOI: 10.4292/wjgpt.v8.i1.60]
URL: https://www.wjgnet.com/2150-5349/full/v8/i1/60.htm
Number Citing Articles
1
M. Markus, A. Abendroth, R. Noureddine, A. Paul, S. Breitenbuecher, I. Virchow, K. W. Schmid, P. Markus, B. Schumacher, M. Wiesweg, J. Wendling, B. Mende, J. T. Siveke, M. Schuler, S. Kasper. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapyJournal of Cancer Research and Clinical Oncology 2021; 147(2): 579 doi: 10.1007/s00432-020-03361-0
2
Jaime de la Fuente, Ayush Sharma, Suresh Chari, Shounak Majumder. Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based studyPancreatology 2019; 19(8): 1043 doi: 10.1016/j.pan.2019.10.002
3
Shuwen Lin, Yinghua Fang, Zhikang Mo, Ye Lin, Chenggang Ji, Zhixiang Jian. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patientsWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01962-0
4
Monocyte as an Emerging Tool for Targeted Drug Delivery: A ReviewCurrent Pharmaceutical Design 2019; 24(44): 5296 doi: 10.2174/1381612825666190102104642
5
Le‐ping Fang, Xiao‐yan Xu, Yu Ji, Pu‐wen Huang. The Prognostic Value of Preoperative Neutrophil‐to‐Lymphocyte Ratio in Resected Patients with Pancreatic AdenocarcinomaWorld Journal of Surgery 2018; 42(11): 3736 doi: 10.1007/s00268-018-4686-7
6
Benjamin E. Ueberroth, Adnan Khan, Kevin J. Zhang, Philip A. Philip. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic AdenocarcinomaJournal of Gastrointestinal Cancer 2021; 52(1): 160 doi: 10.1007/s12029-020-00378-z
7
Muhammad Shehroz Zeeshan, Zeeshan Ramzan. Current controversies and advances in the management of pancreatic adenocarcinomaWorld Journal of Gastrointestinal Oncology 2021; 13(6): 472-494 doi: 10.4251/wjgo.v13.i6.472
8
V. Bebeshko, K. Bruslova, L. Lyashenko, T. Pushkariova, N. Tsvetkova, S. Galkina, V. Vasylenko, Zh. Yaroshenko, A. Zaitseva, L. Gonchar, S. Yatsemirskyi. ASSESSMENT OF QUALITATIVE CHANGES IN PERIPHERAL BLOOD CELLS IN CHILDREN – RESIDENTS OF RADIOLOGICALLY CONTAMINATED TERRITORIES IN THE LATE PERIOD AFTER THE ChNPP ACCIDENTПроблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology 2021; 26: 297 doi: 10.33145/2304-8336-2021-26-297-308
9
Wendi Li, Lianyuan Tao, Meng Lu, Dianrong Xiu. Prognostic role of platelet to lymphocyte ratio in pancreatic cancersMedicine 2018; 97(8): e9616 doi: 10.1097/MD.0000000000009616
10
Ana S. Leal, Phillip Liu, Teresa Krieger-Burke, Bruce Ruggeri, Karen T. Liby. The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic CancerCancers 2020; 13(1): 96 doi: 10.3390/cancers13010096